LGND
NASDAQ · Pharmaceuticals
Ligand Pharmaceuticals
$313.58
+7.38 (+2.41%)
Earnings Summary
Beats (Last 1)
1/1
Avg Surprise
+26.8%
Consecutive Beats
1 quarter
Latest EPS
$2.02
History
1 quarter
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | Q4 FY2026 | $2.41 | — | — | — | — |
| Aug 6, 2026 | Q3 FY2026 | $2.00 | — | — | — | — |
| May 7, 2026 | Q2 FY2026 | $2.09 | — | — | — | — |
| Feb 26, 2026 | Q1 FY2026 | $1.59 | $2.02 | +$0.43 | +26.8% | Beat |